Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antiretroviral therapy
non-nucleoside reverse transcriptase inhibitor |
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:ATCCode |
J05AG04
|
| gptkbp:brand |
gptkb:Intelence
|
| gptkbp:CASNumber |
269055-15-4
|
| gptkbp:developedBy |
gptkb:Janssen_Pharmaceutica
|
| gptkbp:eliminationHalfLife |
41 hours
|
| gptkbp:hasMolecularFormula |
C20H15BrClN6O
|
| https://www.w3.org/2000/01/rdf-schema#label |
etravirine
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:proteinBinding |
99.9%
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea headache rash |
| gptkbp:usedFor |
HIV infection
|
| gptkbp:bfsParent |
gptkb:NNRTIs
|
| gptkbp:bfsLayer |
5
|